SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : TATRADER GIZZARD STUDY--Stocks 12.00 or Less..... -- Ignore unavailable to you. Want to Upgrade?


To: TATRADER who wrote (52457)12/27/2005 9:48:17 AM
From: Smiling Bob  Read Replies (1) | Respond to of 59879
 
RIGL looks like it's got its base formed and should be all higher from here



To: TATRADER who wrote (52457)12/27/2005 9:55:23 AM
From: Sam Nizam  Read Replies (1) | Respond to of 59879
 
Mark what do you think of BIOM



To: TATRADER who wrote (52457)12/27/2005 10:33:47 AM
From: smahi  Read Replies (1) | Respond to of 59879
 
EGHT is getting closer



To: TATRADER who wrote (52457)12/27/2005 10:48:07 AM
From: hotlinktuna  Respond to of 59879
 
Nice Mark, trying CMT 6.78 and 6.64 now in 6.50's...liked their last earnings report: Core Molding Technologies Reports Third Quarter 2005 Results
Thursday November 3, 8:45 am ET

COLUMBUS, Ohio, Nov. 3 /PRNewswire-FirstCall/ -- Core Molding Technologies, Inc. (Amex: CMT - News) today announced results for the third quarter and nine months ended September 30, 2005.
ADVERTISEMENT


The Company recorded net income for the third quarter of 2005 of $1,511,000, or $.15 per basic share and $.14 per diluted share, compared with $478,000, or $.05 per basic and diluted share, in the third quarter of 2004. Total net sales for the third quarter were $31,614,000 compared with $25,928,000 in the same quarter of 2004. Product sales for the three months ended September 30, 2005 increased 25 percent to $31,045,000 from $24,924,000 for the similar period in 2004. Tooling sales totaled $569,000 for the third quarter 2005 versus $1,004,000 for the similar time period in 2004. Revenue from tooling projects is sporadic in nature and does not represent a recurring trend.

For the first nine months of 2005, net income was $5,202,000, or $.53 per basic share and $.50 per diluted share, compared with $2,332,000, or $.24 per basic and diluted share, in the similar period of 2004. Total net sales for the first nine months of 2005 were $97,790,000 compared with $76,776,000 in the first nine months of 2004. Product sales for the first nine months of 2005 increased 24 percent to $93,262,000 from $75,319,000 for the similar period in 2004. Tooling sales totaled $4,528,000 for the first nine months of 2005 versus $1,457,000 for the similar period in 2004.

"Our third quarter and year to date earnings have been favorably impacted by the increases in product sales and by improvement in operational effectiveness offset by increased costs of raw materials," said James L. Simonton, president and chief executive officer. "The additional sales from our recently acquired operation in Cincinnati partially offset our normal third quarter seasonal softness due to some of our largest customers' planned vacation shutdowns. We are pleased with the transition efforts in Cincinnati and with their operational performance which has met our initial expectations."

Simonton cautioned that the Company continues to experience raw material and energy related price increases, primarily as a result of the volatility in the petrochemical and natural gas markets. The Company remains focused on identifying lower cost alternatives wherever possible to mitigate these increased production costs.

The Company also announced it was named to the new Russell Microcap (TM) Index when Russell Investment Group reconstituted its family of U.S. Indexes on June 24. Russell recently posted a membership list for the Russell Microcap at www.russell.com/US/indexes.

Core was also named to the Fortune Small Business list of "America's Fastest-Growing Small Public Companies" earlier in the quarter.

Core Molding Technologies, Inc. is a compounder of sheet molding composites (SMC) and molder of fiberglass reinforced plastics The Company's processing capabilities include the compression molding of SMC, resin transfer molding, multiple insert tooling (MIT) resin transfer molding, spray up and hand lay up processes. The Company produces high quality fiberglass reinforced, molded products and SMC materials for varied markets, including light, medium and heavy-duty trucks, automobiles, automobile aftermarket, personal watercraft and other commercial products. Core Molding Technologies, with its headquarters in Columbus, Ohio, operates plants in Columbus, Cincinnati, Ohio, Gaffney, South Carolina, and Matamoros, Mexico.

This press release contains certain forward-looking statements within the meaning of the federal securities laws. As a general matter, forward-looking statements are those focused upon future plans, objectives or performance as opposed to historical items and include statements of anticipated events or trends and expectations and beliefs relating to matters not historical in nature. Such forward-looking statements involve known and unknown risks and are subject to uncertainties and factors relating to Core Molding Technologies' operations and business environment, all of which are difficult to predict and many of which are beyond Core Molding Technologies' control. These uncertainties and factors could cause Core Molding Technologies' actual results to differ materially from those matters expressed in or implied by such forward-looking statements.

Core Molding Technologies believes that the following factors, among others, could affect its future performance and cause actual results to differ materially from those expressed or implied by forward-looking statements made in this press release: business conditions in the plastics, transportation, watercraft and commercial product industries; general economic conditions in the markets in which Core Molding Technologies operates; dependence upon four major customers as the primary source of Core Molding Technologies' sales revenues; recent efforts of Core Molding Technologies to expand its customer base; failure of Core Molding Technologies' suppliers to perform their contractual obligations; the availability of raw materials; inflationary pressures; new technologies; competitive and regulatory matters; labor relations; the loss or inability of Core Molding Technologies to attract key personnel; the availability of capital; the ability of Core Molding Technologies to provide on-time delivery to customers, which may require additional shipping expenses to ensure on-time delivery or otherwise result in late fees; risk of cancellation or rescheduling of orders; and management's decision to pursue new products or businesses which involve additional costs, risks or capital expenditures.

CORE MOLDING TECHNOLOGIES, INC.
Condensed Income Statement
(in thousands, except per share data)

Three Months Ended Nine Months Ended
09/30/05 09/30/04 09/30/05 09/30/04
(Unaudited) (Unaudited) (Unaudited) (Unaudited)

Product Sales $31,045 $24,924 $93,262 $75,319
Tooling Sales 569 1,004 4,528 1,457
Net Sales 31,614 25,928 97,790 76,776
Cost of Sales 26,127 22,562 79,161 64,354
Gross Margin 5,487
3,366 18,629 12,422
Selling, General and 3,000 2,430 9,588 8,030
Admin. Expense
Operating Income 2,487 936 9,041 4,392
Interest Expense - Net 118 208 454 678
Income before Taxes 2,369 728 8,587 3,714
Income Tax Expense 858 250 3,385 1,382
Net Income $1,511 $478 $5,202 $2,332
Net Income per Common Share
Basic $0.15 $0.05 $0.53 $0.24
Diluted $0.14 $0.05 $0.50 $0.24
Weighted Average Shares
Outstanding:
Basic 9,990 9,779 9,876 9,779
Diluted 10,578 9,789 10,388 9,838

Condensed Balance Sheet
(in thousands)
As of As of
09/30/05 12/31/04
(Unaudited)
Assets
Cash and Investments $8,374 $5,358
Accounts Receivable 29,353 19,131
Inventories 7,417 6,544
Other Current Assets 3,870 4,165
Property, Plant & Equipment - net 22,611 22,730
Deferred Tax Asset - net 6,180 9,362
Other Assets 1,506 1,670
Total Assets $79,311 $68,960

Liabilities and Stockholders' Equity
Current Portion of Long-term Debt $1,766 $1,736
Current Portion of Long-term Gain 367 454
Accounts Payable 17,235 14,054
Accrued Liabilities 7,180 5,424
Long-term Debt 10,041 11,371
Interest Rate Swaps 178 475
Graduated Lease Payments 314 486
Deferred Long-term Gain 395 648
Post Retirement Benefits Liability 9,421 8,035
Stockholders' Equity 32,414 26,277
Total Liabilities and Stockholders' Equity $79,311 $68,960

--------------------------------------------------------------------------------
Source: Core Molding Technologies, Inc.



To: TATRADER who wrote (52457)12/27/2005 3:05:47 PM
From: hotlinktuna  Read Replies (2) | Respond to of 59879
 
After several successes with DMC it caught me for just over a buck this round...carp! Added a recent Amex IPO today, REX 1.41 +.23 here: REX 1.41 +.23 a bio on the AMEX debuted the 23rd: American Stock Exchange Lists Common Stock of ViRexx Medical Corporation
Friday December 23, 2:09 pm ET

NEW YORK, Dec. 23 /PRNewswire/ -- The American Stock Exchange® (Amex®) today listed the common stock of ViRexx Medical Corporation, under the ticker symbol REX.
ViRexx Medical Corp. is an Edmonton, Alberta-based biotechnology company focused on the development of novel therapeutic products for the treatment of cancer and chronic viral infections. ViRexx's most advanced programs include drug candidates for the treatment of ovarian cancer, chronic Hepatitis B & C and solid tumors.

ADVERTISEMENT

"The American Stock Exchange gladly welcomes ViRexx Medical Corporation to our market," said John McGonegal, senior vice president of Amex's equities group. "ViRexx performs important work in the medical industry, and we hope to be supportive of its endeavors as it seeks to expand and deliver its services to a demanding marketplace."

Dr. Lorne Tyrrell, Chief Executive Officer of ViRexx, said, "Achieving an Amex listing is part of a larger strategy to increase our exposure and presence in the U.S. as we increase our clinical activity. This listing supports ViRexx's product development by increasing our access to potential U.S. investors."

The company has chosen AIM Securities Inc. as its specialist. For further information on REX and other Amex-listed companies, please visit www.amex.com.

The American Stock Exchange® (Amex®) is the only primary exchange that offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 150 ETFs. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, please visit www.amex.com.

--------------------------------------------------------------------------------
Source: American Stock Exchange